Investigational Site Number : 6160007

Warsaw 02-962

0 studies enrolling now · 2 studies all time

What they study most

Dermatitis Atopic, Type 1 Diabetes Mellitus

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus — Completed